BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37427332)

  • 1. ISLR interacts with MGAT5 to promote the malignant progression of human gastric cancer AGS cells.
    Zuo B; Huang Q; Yu W; Xu J
    Iran J Basic Med Sci; 2023; 26(8):960-965. PubMed ID: 37427332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of immunoglobulin superfamily containing leucine-rich repeat inhibits gastric cancer cell growth and metastasis by regulating epithelial-mesenchymal transition.
    Sun A; Li J; Kong W; Jiang X
    Bioengineered; 2022 May; 13(5):13544-13554. PubMed ID: 35653801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of
    Zhang P; Li Z; Yang G
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISLR affects colon cancer progression by regulating the epithelial-mesenchymal transition signaling pathway.
    Chi C; Liu T; Yang S; Wang B; Han W; Li J
    Anticancer Drugs; 2022 Jan; 33(1):e670-e679. PubMed ID: 34520435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13.
    Wang Y; Tan Z; Li X; Zhang L; Pei X
    Front Oncol; 2023; 13():1133476. PubMed ID: 37256183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-box and leucine-rich repeat 6 promotes gastric cancer progression
    Meng L; Hu YT; Xu AM
    World J Gastrointest Oncol; 2023 Mar; 15(3):490-503. PubMed ID: 37009323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF5‑mediated expression of CARD11 promotes the progression of gastric cancer.
    Li Q; Li S; Li Z; Xu H; Zhang W
    Exp Ther Med; 2023 Sep; 26(3):422. PubMed ID: 37602310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analysis Regarding the Association Between the
    Li S; Zhao W; Sun M
    Front Genet; 2020; 11():620. PubMed ID: 32612640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
    Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
    Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EDIL3 regulates gastric cancer cell migration, invasion and epithelial-mesenchymal transition via TGF-β1/XIST/miR-137 feedback loop.
    Zhang L; Peng KW; Wang B; Yang XF; Zhang ZM
    Transl Cancer Res; 2020 Oct; 9(10):6313-6330. PubMed ID: 35117240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylglucosaminyltransferase V inhibits the invasion of trophoblast cells by attenuating MMP2/9 activity in early human pregnancy.
    Deng Q; Chen Y; Yin N; Shan N; Luo X; Tong C; Zhang H; Baker PN; Liu X; Qi H
    Placenta; 2015 Nov; 36(11):1291-9. PubMed ID: 26349781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway.
    Chen QF; Hu CF; Sun K; Lang YP
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.
    Li N; Meng D; Xu Y; Gao L; Shen F; Tie X; Zhang Y; Yi Z; Shen W; Liu Z; Xu Z
    Biomed Res Int; 2020; 2020():7467104. PubMed ID: 33376737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIPE2 inhibits the migration and invasion of endometrial cells by targeting β-catenin to reverse epithelial-mesenchymal transition.
    Liu Y; Wang X; Wan L; Liu X; Yu H; Zhang D; Sun Y; Shi Y; Zhang L; Zhou H; Wang J; Wei Z
    Hum Reprod; 2020 Jun; 35(6):1377-1390. PubMed ID: 32469403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition.
    Zhou D; He Y; Li H; Huang W
    Exp Ther Med; 2021 Jul; 22(1):770. PubMed ID: 34055069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sema3A alleviates the malignant behaviors of gastric cancer cells by inhibiting NRP-1.
    Yang H; Zhou Y; Wang L; Lv M; Sun J; Luo Z; He J
    Curr Mol Med; 2023 Aug; ():. PubMed ID: 37533240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
    Zuo X; Cai J; Chen Z; Li Y; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic Elongation Factor 1Alpha-2 (EEF1A2) Participates in the Progression of Gastric Cancer via Interaction with Heat Shock Protein B8 (HSPB8).
    Li J; Tang X; Zhang Z
    Ann Clin Lab Sci; 2023 May; 53(3):398-408. PubMed ID: 37437931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.